Additional file 3: Table S1. of MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer

The sequences of all the primers. Table S2. The antibodies of all proteins. Table S3. Associations of miR-30d expression with various clinicopathological parameters of PCa patients based on Taylor and TCGA datasets. Table S4. Univariate and multivariate analyses on prognostic implications of various clinicopathological parameters of human PCa based on Taylor dataset. Table S5. One hundred and forty-six differentially expressed gene with more than 2 ratio both in LNCaP and DU145 cells from gene expression profile. Table S6. Thirty-six putative targets of miR-30d which were also downregulated in both miR-30d-transfected LNCaP and DU145 cells according to the gene microarray analysis. Table S7. The pathway enrichment analysis based on KEGG database. Table S8. Associations of MYPT1 protein expression with clinicopathological characteristics of PCa patients. Table S9. Cox proportional hazards multivariate model for evaluating the prognostic values of various factors in human prostate cancer based on Taylor dataset. Table S10. Associations between MYPT1 expression in PCa tissues and Gleason score. Table S11. Associations between miR-30d expression in PCa tissues and Gleason score based on Taylor and TCGA datasets. (DOCX 58 kb)